{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:51:11Z","timestamp":1771379471439,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clineu-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.clineuro.2016.09.016","type":"journal-article","created":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T18:45:58Z","timestamp":1475088358000},"page":"181-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical\/interventional treatments"],"prefix":"10.1016","volume":"150","author":[{"given":"Patrick M.","family":"House","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan R.G.","family":"Stodieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2016.09.016_bib0005","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2016.09.016_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00415-013-7019-7","article-title":"Review: idiopathic intracranial hypertension; research progress and emerging themes","volume":"261","author":"Batra","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2016.09.016_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM199308263290917","article-title":"Growth Hormone, Insulin-like growth factor I and benign intracranial hypertension","volume":"329","author":"Malozowski","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2016.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/0140-6736(93)92150-R","article-title":"Octreotide in benign intracranial hypertension","volume":"342","author":"Antaraki","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2016.09.016_bib0025","first-page":"1","article-title":"Octreotide: a therapeutic option for idiopathic intracranial hypertension","volume":"10","author":"Panagopoulos","year":"2007","journal-title":"Neurol. Neurophysiol. Neurosci."},{"issue":"16","key":"10.1016\/j.clineuro.2016.09.016_bib0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1177\/0333102411424211","article-title":"Treatment of idiopathic intracranial hypertension: is there a place for octreotide?","volume":"31","author":"Deftereos","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2016.09.016_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bmj.295.6592.247","article-title":"Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours","volume":"295","author":"Williams","year":"1987","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"16","key":"10.1016\/j.clineuro.2016.09.016_bib0040","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Idiopathic intracranial hypertension study group writing committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the Idiopathic intracranial hypertension treatment trial","volume":"311","author":"NORDIC (Neuro-Ophthalmology Research Disease Investigator Consortium)","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clineuro.2016.09.016_bib0045","first-page":"87","article-title":"Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects","volume":"9","author":"Julayanont","year":"2016","journal-title":"J. Pain Res."},{"issue":"10","key":"10.1016\/j.clineuro.2016.09.016_bib0050","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bjophthalmol-2014-304953","article-title":"Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion","volume":"98","author":"Fonseca","year":"2014","journal-title":"Br. J. Ophtalmol."},{"issue":"16","key":"10.1016\/j.clineuro.2016.09.016_bib0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/0333102411423305","article-title":"Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review","volume":"31","author":"Sinclair","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2016.09.016_bib0060","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/s11102-012-0400-1","article-title":"Desensitization treatment for hypersensitivity reaction to octreotide in an acromegalic patient","volume":"15","author":"Dadzie","year":"2012","journal-title":"Pituitary"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384671630347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384671630347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T22:59:29Z","timestamp":1536361169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384671630347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":12,"alternative-id":["S030384671630347X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2016.09.016","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical\/interventional treatments","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2016.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}